Profile
Hagop Youssoufian currently works at American Society for Clinical Investigation, as Member, Verastem, Inc., as Head-Medical Strategy from 2018, and Oncxerna Therapeutics, Inc., as Chief Medical Officer from 2020.
Dr. Youssoufian also formerly worked at ImClone LLC, as Chief Medical Officer, Progenics Pharmaceuticals, Inc., as Executive Vice President-Research & Development from 2013 to 2014, DNIB Unwind, Inc., as Chief Medical Officer, Baylor College of Medicine, as Associate Professor, Alaunos Therapeutics, Inc., as Chief Medical Officer from 2011 to 2013, and Harvard Medical School, as Assistant Professor.
Dr. Youssoufian received his undergraduate degree from Boston College and graduate degree and doctorate degree from UMass Chan Medical School.
Hagop Youssoufian active positions
| Companies | Position | Start |
|---|---|---|
| VERASTEM, INC. | Corporate Officer/Principal | 2017-01-18 |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Corporate Officer/Principal | - |
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Chief Tech/Sci/R&D Officer | 2020-07-08 |
Former positions of Hagop Youssoufian
| Companies | Position | End |
|---|---|---|
| PROGENICS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2014-09-18 |
| ALAUNOS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2013-04-01 |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| DNIB UNWIND INC | Chief Tech/Sci/R&D Officer | - |
Training of Hagop Youssoufian
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology Develops novel therapeutic products and blood cell growth factors for the treatment of cancer | Health Technology |
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
DNIB Unwind, Inc.
DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verastem, Inc.
Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Oncxerna Therapeutics, Inc.
Oncxerna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Health Technology |
- Stock Market
- Insiders
- Hagop Youssoufian
















